flumazenil has been researched along with alfentanil in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boysen, K; Crawford, ME; Krintel, JJ; Sonne, NM; Valentin, N; Wegmann, F | 1 |
| Harrop-Griffiths, AW; Jewkes, DA; Watson, NA | 1 |
| Andersen, P; Christiansen, C; Jarnvig, IL; Jørgensen, B; Skielboe, M; Weber, M | 1 |
| Hartvig, P; Nilsson, A; Persson, MP | 2 |
| Bovill, JG; Breimer, LT; Hennis, PJ; Spierdijk, J | 1 |
| Hole, A; Nilsen, OG; Raeder, JC | 1 |
| Hansen, PA; Jensen, AG; Lybecker, H; Møller, JT | 1 |
| Blouin, RT; Conard, PF; Gross, JB; Häussler, J; Zandsberg, S | 1 |
| Feng, J; Kendig, JJ | 1 |
1 review(s) available for flumazenil and alfentanil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for flumazenil and alfentanil
| Article | Year |
|---|---|
Recovery after total intravenous anaesthesia using combined midazolam/alfentanil infusion and reversal with flumazenil.
Topics: Acoustic Stimulation; Adult; Alfentanil; Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthesia, Intravenous; Blood Pressure; Female; Flumazenil; Glasgow Coma Scale; Heart Rate; Humans; Infusions, Intravenous; Male; Midazolam; Middle Aged; Nitrous Oxide; Patient Satisfaction; Reaction Time; Respiration | 1991 |
Antagonism of diazepam sedation by flumazenil.
Topics: Aged; Aged, 80 and over; Alfentanil; Anesthesia, General; Carbon Dioxide; Diazepam; Double-Blind Method; Flumazenil; Humans; Middle Aged; Nitrous Oxide; Oxygen; Randomized Controlled Trials as Topic; Wakefulness | 1989 |
Effects of flumazenil on post-operative recovery after total intravenous anesthesia with midazolam and alfentanil.
Topics: Alfentanil; Anesthesia Recovery Period; Anesthesia, Intravenous; Female; Fentanyl; Flumazenil; Humans; Hysterectomy; Midazolam; Postoperative Period; Receptors, GABA-A | 1988 |
The efficacy of flumazenil versus physostigmine after midazolam-alfentanil anaesthesia in man.
Topics: Adult; Alfentanil; Anesthesia; Anesthesia Recovery Period; Double-Blind Method; Female; Fentanyl; Flumazenil; Humans; Male; Midazolam; Nitrous Oxide; Physostigmine; Random Allocation; Vecuronium Bromide | 1988 |
Effects of the benzodiazepine antagonist flumazenil on postoperative performance following total intravenous anaesthesia with midazolam and alfentanil.
Topics: Alfentanil; Anesthesia Recovery Period; Anesthesia, Intravenous; Cooperative Behavior; Female; Fentanyl; Flumazenil; Humans; Memory; Midazolam; Nitrous Oxide; Orientation; Postoperative Period; Thiopental | 1988 |
Pharmacokinetics of midazolam and alfentanil in outpatient general anesthesia. A study with concomitant thiopentone, flumazenil or placebo administration.
Topics: Adult; Alfentanil; Ambulatory Surgical Procedures; Anesthesia, General; Female; Fentanyl; Flumazenil; Humans; Midazolam; Middle Aged; Nitrous Oxide; Placebos; Preanesthetic Medication; Thiopental; Time Factors | 1988 |
A random trial comparing recovery after midazolam-alfentanil anesthesia with and without reversal with flumazenil, and standardized neurolept anesthesia for major gynecologic surgery.
Topics: Adult; Aged; Alfentanil; Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Intravenous; Blood Pressure; Double-Blind Method; Female; Flumazenil; Genitalia, Female; Heart Rate; Humans; Midazolam; Middle Aged; Neuroleptanalgesia; Nitrous Oxide; Placebos; Respiration | 1995 |
Effect of flumazenil on ventilatory drive during sedation with midazolam and alfentanil.
Topics: Adult; Alfentanil; Analgesics, Opioid; Antidotes; Benzodiazepines; Carbon Dioxide; Conscious Sedation; Consciousness; Cross-Over Studies; Depression, Chemical; Double-Blind Method; Drug Interactions; Female; Flumazenil; Humans; Hypnotics and Sedatives; Hypoxia; Infusions, Intravenous; Male; Midazolam; Respiration | 1996 |
9 other study(ies) available for flumazenil and alfentanil
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Midazolam and flumazenil in the anaesthetic management of trigeminal nerve thermocoagulation.
Topics: Alfentanil; Blood Pressure; Electrocoagulation; Flicker Fusion; Flumazenil; Heart Rate; Humans; Midazolam; Middle Aged; Time Factors; Trigeminal Nerve; Trigeminal Neuralgia | 1990 |
Synergistic interactions between midazolam and alfentanil in isolated neonatal rat spinal cord.
Topics: Alfentanil; Analgesics, Opioid; Animals; Bicuculline; Dose-Response Relationship, Drug; Drug Synergism; Evoked Potentials; Flumazenil; Hypnotics and Sedatives; Midazolam; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Spinal Cord | 1996 |